VC-Backed Biopharma Co. Anchiano Launches $30.5M IPO
Venture capital-backed Anchiano Therapeutics Ltd. made its market debut Tuesday through a $30.5 million initial public offering steered by four firms, allowing the Israel-based biopharmaceutical company to raise capital in the...To view the full article, register now.
Already a subscriber? Click here to view full article